Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilisation.
GO TO DETAILS ProductsMetformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilisation.
Copyright 2025 by Quaecon Pharmaceuticals Inc.
